Table 2.

Epidemiological, clinical and pathological features of patients treated with TKI and who developed adrenal insufficiency during follow-up

Total pts (n = 9)
Characteristics	No.	%
Sex
Male  Female	6 3	66.7 33.3
Age at diagnosis, years
Mean  Median  Range	53.4 52.0 39–67
Age at screening, years
Mean  Median  Range	60.3 63.0 39–73
Histology
PTC  FTC  MTC  PDTC	2 3 1 3	22.3 33.3 11.1 33.3
TKI at ACTH test
Lenvatinib  Vandetanib  Cabozantinib	7 1 1	77.8 11.1 11.1
Lines of TKI
1  2  4	5 3 1	55.6 33.3 11.1